Haitham Kalil

Polystyrene nanoplastic (PSNP) contaminants are widespread in the environment with potential adverse effects on male reproductive health. This study investigated the molecular mechanisms underlying PSNP-induced testicular dysfunction in rats and evaluated the protective effects of pirfenidone (PF) and tirzepatide (TZP). Twenty-four adult albino rats were included in the study. Eighteen rats received PSNP (1.5 mg/kg/day, orally) for 8 weeks, while six age-matched rats receiving deionized water by oral gavage served as negative controls. Beginning in week 5, PSNP-exposed rats were assigned to three groups (n = 6/group): vehicle-treated PSNP, PSNP+PF (100 mg/kg/day, orally), and PSNP+TZP (0.5 mg/kg/week, subcutaneously), with treatments continued for 4 weeks. PSNP exposure impaired testicular architecture, disrupted the blood–testis barrier, compromised steroidogenesis, and promoted testicular fibrosis. It also induced oxidative stress through dysregulation of the TXNIP/TRX system and enhanced pyroptosis, potentially through activation of the HMGB1/TLR4/NF-κB/NLRP3 signaling pathway. Treatment with either PF or TZP markedly attenuated PSNP-induced alterations, preserved blood–testis barrier integrity, improved steroidogenic function, and reduced fibrosis, oxidative stress, and pyroptosis. These protective effects were associated with modulation of the TXNIP/TRX system and suppression of HMGB1/TLR4/NF-κB/NLRP3-mediated pyroptotic signaling. Collectively, these findings identify PF and TZP as promising preclinical candidates for mitigating PSNP-induced testicular toxicity. Further mechanistic and translational studies are warranted to validate their potential role in protecting male reproductive health.

Moxifloxacin-based Schiff-base ligands provide a useful platform for tuning the coordination and biological properties of fluoroquinolone derivatives. Here, a moxifloxacin–salicylaldehyde hydrazone ligand (MOX-S) was prepared and coordinated with cobalt(II), nickel(II), copper(II), oxovanadium(IV), and gadolinium(III) ions to obtain a series of metal complexes. Citrate-stabilized gold nanoparticles (AuNPs) were also prepared and functionalized with MOX-S and the Cu(II) complex to evaluate the effect of nanoformulation on biological performance. The compounds were characterized using complementary analytical, spectroscopic, magnetic, thermal, and microscopic techniques. The combined data support 1:2 metal-to-ligand formulations for the complexes and indicate coordination mainly through the azomethine nitrogen and oxygen donor sites of MOX-S. In antimicrobial screening, the activity was strongly metal- and organism-dependent. Cu–MOX-S and VO–MOX-S showed the most pronounced activity against Gram-positive bacteria, with inhibition zones of up to 30 mm, while Cu–MOX-S displayed MIC values of 19.53 and 39.06 µg mL⁻¹ against Bacillus subtilis and Staphylococcus aureus, respectively. Cytotoxicity assays showed that MOX-S was more active than moxifloxacin against MCF-7 and HepG2 cells, while Cu–MOX-S showed enhanced potency, particularly toward HepG2 cells, with an IC₅₀ of 0.98 µM and a selectivity index of 5.97. AuNP formulations further increased the apparent antiproliferative potency in the tested cancer cell lines, giving sub-micromolar IC₅₀ values. Computational analyses, including DFT-based electronic descriptors and molecular docking, provided qualitative support for the experimentally observed coordination and cytotoxicity trends. Overall, metal coordination and AuNP formulations provide complementary strategies for modulating the physicochemical and in vitro biological behavior of this moxifloxacin-derived hydrazone scaffold.

This study reports the synthesis, spectroscopic characterization, and biological evaluation of a novel moxifloxacin hydrazide derivative (MOX-H) and its metal complexes with Co(II), Ni(II), Cu(II), VO(IV), and Gd(III). The ligand was synthesized by hydrazinolysis of moxifloxacin hydrochloride, and the resulting hydrazide was subsequently complexed with the respective metal salts. The interaction between MOX-H and the metal ions yielded the corresponding complexes, formulated as [Co(H₂O)Cl(MOX-H)₂]Cl·2.5H₂O, [Ni(H₂O)Cl(MOX-H)₂]Cl.4.5H₂O, [VO(MOX-H)₂]SO₄.3.5H₂O, [Gd (H₂O)(MOX-H)₂(NO₃)₂]NO₃.2H₂O, and [Cu(MOX-H)₂(H₂O)Cl]Cl·xH₂O (where x = 2, 2.5, 0.5, for products synthesized via template, microwave-assisted, and hydrothermal methods, respectively). The synthesized analogues were characterized by elemental analysis (CHN), FT-IR, UV-visible, and ¹H NMR spectroscopy, and mass spectrometry, as well as thermogravimetric (TG/DTG) and magnetic measurements. FT-IR spectra confirmed coordination through the hydrazide carbonyl and amine groups, while UV–visible and magnetic data indicated predominantly octahedral geometries. The thermal behavior exhibited multistep decomposition with activation parameters supporting exothermic processes. When compared to the free ligand, the metal complexes showed increased antimicrobial activity against both Gram-positive and Gram-negative bacteria and fungus species, particularly for the Co(II) and Cu(II) complexes, which showed the largest inhibition zones. The Cu(II)–MOX-H complex exhibited the lowest MIC values (4.88–9.76 µg/mL) among all tested compounds, confirming its outstanding antibacterial potency and high sensitivity compared to the free ligand and standard drug. Cytotoxicity assays demonstrated selective anticancer activity, with the Cu(II)–MOX-H complex showing the highest potency (IC₅₀ ≈ 2.95 µM against MCF-7 and IC₅₀ ≈ 0.98 µM against HepG-2), while maintaining minimal toxicity toward normal cells. These findings were corroborated by molecular docking investigations, which showed that the MOX-H complexes had substantial binding affinities (−9 to −10 kcal/mol) toward DNA topoisomerase II, consistent with their observed biological effects.

Background/Objectives: Cancer remains one of the most significant challenges in modern medicine, requiring the continuous development of novel molecular scaffolds with anticancer potential that act through multiple pathways. Heterocyclic compounds incorporating indole, triazole, oxadiazole, and thiadiazine motifs have attracted considerable attention due to their diverse pharmacological activities. This study aimed to design, synthesize, and evaluate new hybrid heterocyclic systems, including 1,2,4-triazole, 1,3,4-oxadiazole, and thiadiazine motifs, targeting liver and breast cancer. Methods: A series of indolyl-based heterocyclic compounds was synthesized using efficient and environmentally friendly protocols. Indolyl-triazol-thiadiazin-6-ol 5 was prepared via solvent-free fusion of esters 2 and 3 or the corresponding acid 4. Oxadiazole derivatives were produced by reacting hydrazide intermediates with carbon disulfide. Triazole derivatives were synthesized via cylization of thiosemicarbazide 9 in aqueous KOH (4.0 N). Structural characterization was performed using Fourier Transform InfraRed (FTIR), ¹H and ¹³C NMR spectroscopy, and electron impact mass spectrometry (EIMS). Cytotoxic activity was evaluated against liver and breast cancer cell lines, and VEGFR-2 kinase inhibition was assessed for selected derivatives. Results: The synthesized compounds demonstrated notable cytotoxicity activity, with compounds 4, 5, and 9 exhibiting IC₅₀ values in the low micromolar range. Enzymatic assays revealed that compounds 4 and 9 showed strong VEGFR-2 inhibition (97.9% and 96.4%, respectively), indicating apoptosis-inducing effects. Conclusions: The synthesized indolyl-based hybrid heterocycles represent a promising chemotype with in vitro cytotoxic activity and VEGFR-2 inhibitory effects, supporting further investigation, optimization, and mechanistic studies to evaluate their potential lead for anticancer drug development.

This manuscript reports a scalable, solution-cast strategy to upcycle waste-derived functional fillers into electroactive poly(vinylidene fluoride) (PVDF) hybrid membranes for promising dielectric/piezoelectric applications.

This study investigates the development and sensing profile of synthetic melanin nanoparticle-coated electrodes for the electrochemical detection of heavy metals, including lead (Pb), cadmium (Cd), cobalt (Co), zinc (Zn), nickel (Ni), and iron (Fe). Synthetic melanin films were prepared in situ by the deacetylation of diacetoxy indole (DAI) to dihydroxy indole (DHI), followed by the deposition of DHI monomers onto indium tin oxide (ITO) and glassy carbon electrodes (GCE) using cyclic voltammetry (CV), forming a thin layer of synthetic melanin film. The deposition process was characterized by electrochemical quartz crystal microbalance (EQCM) in combination with linear sweep voltammetry (LSV) and amperometry to determine the mass and thickness of the deposited film. Surface morphology and elemental composition were examined using scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDX). In contrast, Fourier-transform infrared (FTIR) and UV–Vis spectroscopy confirmed the melanin’s chemical structure and its polyphenolic functional groups. Differential pulse voltammetry (DPV) and amperometry were employed to evaluate the melanin films’ electrochemical activity and sensitivity for detecting heavy metal ions. Reproducibility and repeatability were rigorously assessed, showing consistent electrochemical performance across multiple electrodes and trials. A comparative analysis of ITO, GCE, and graphite electrodes was conducted to identify the most suitable substrate for melanin film preparation, focusing on stability, electrochemical response, and metal ion sensing efficiency. Finally, the applicability of melanin-coated electrodes was tested on in-house heavy metal water samples, exploring their potential for practical environmental monitoring of toxic heavy metals. The findings highlight synthetic melanin-coated electrodes as a promising platform for sensitive and reliable detection of iron with a sensitivity of 106 nA/ppm and a limit of quantification as low as 1 ppm.

In this study, we synthesized a novel trimethoprim derivative, 4-(((2-amino-5-(3,4,5-trimethoxybenzyl) pyrimidine-4-yl)imino)methyl)benzene-1,3-diol (HD), by the reaction of trimethoprim with 2,4-dihydroxybenzaldehyde. We then prepared metal complexes of this derivative with Cu(II), Co(II), Ni(II), Ag(I), and Zn(II) and functionalized them with ZnO and Au nanoparticles. Their structures were confirmed through ¹H NMR, mass spectrometry, FTIR, conductivity, thermal analysis, magnetic susceptibility, X-ray diffraction, UV-Vis spectroscopy, and TEM, revealing octahedral geometries for all complexes. Surface features were investigated using density functional theory (DFT) analysis. Pharmacokinetic parameters and target enzymes for HD and its complexes were computed using the SwissADME web tool, with the BOILED-Egg model indicating that HD and its Cu complex should be passively permeable via the blood-brain barrier and highly absorbed by the gastrointestinal tract (GIT), unlike the Ni, Co, Ag, and Zn complexes, which are predicted to show low GIT absorption. Molecular docking studies with the Caspase-3 enzyme (PDB code: 3GJQ) using the AutoDock 4.2 software demonstrated binding energies of −7.66, −8.36, −9.05, −8.62, −6.90, and −7.81 kcal/mol for HD and the Cu, Co, Ni, Ag, and Zn complexes, respectively, compared to −6.54 and −4.63 kcal/mol for TMP and 5-FU (5-fluorouracil), indicating a potential superior anticancer potential of the novel compounds. The anticancer activities of these complexes were evaluated using the MTT assay. The IC₅₀ values for 5-FU, TMP, HD, Cu-HD, HD@ZnONPs, Cu-HD@ZnONPs, HD@AuNPs, and Cu-HD@AuNPs were found to be 32.53, 80.76, 114.7, 61.66, 77, 53.13, 55.06, and 50.81 µg/mL, respectively. Notably, all derivatives exhibited higher activity against the HepG-2 cancer cell line than TMP, except for HD, which showed similar effectiveness to TMP. Real-time PCR analysis revealed that the Au-HD@AuNPs and Cu-HD@AuNPs significantly increased caspase-3 inhibition by 4.35- and 4.5-fold and P53 expression by 3.05- and 3.41-fold, respectively, indicating enhanced pro-apoptotic gene expression and apoptosis induction in HepG2 cells. Our findings demonstrate that these novel derivatives possess significant anticancer properties, with some complexes showing superior activity compared to standard drugs such as 5-Fluorouracil (5-FU) and Trimethoprim (TMP). This study highlights the potential of these nanocomposites as promising candidates for cancer therapy.

Eco-friendly iron and manganese oxide nanoparticles (Fe₂O₃ and Mn₂O₃) were synthesized and integrated into graphene sheets to form uniform composites. These composites were then embedded in polyvinyl alcohol (PVA) fibers using electrospinning. Comprehensive characterization of the composites and the final composite fibers was conducted using XRD, FE-SEM, and FTIR to analyze their structural complexity and morphological differences. The antibacterial efficacy of the resulting PVA nanofibers was evaluated against Escherichia coli, which is a common pathogen in hospital environments. The results show a significant bactericidal effect against these bacteria, which highlights their potential in medical applications, such as functional bandages and wound dressings. This study paves the way for potential commercial applications of these nanofibers in healthcare settings.

A new ibuprofen derivative, (E)-2-(4-isobutylphenyl)-N′-(4-oxopentan-2-ylidene) propane hydrazide (IA), was synthesized, along with its metal complexes with Co, Cu, Ni, Gd, and Sm, to investigate their anti-inflammatory efficacy and COX-2 inhibition potential. Comprehensive characterization, including ¹H NMR, MS, FTIR, UV–vis spectroscopy, and DFT analysis, were employed to determine the structural configurations, revealing unique motifs for Gd/Sm (capped square antiprismatic/tricapped trigonal prismatic) and Cu/Ni/Co (octahedral) complexes. Molecular docking with the COX-2 enzyme (PDB code: 5IKT) and pharmacokinetic assessments through SwissADME indicated that these compounds have superior binding energies and pharmacokinetic profiles, including BBB permeability and gastrointestinal absorption, compared to the traditional ibuprofen standalone. Their significantly lower IC50 values further suggest a higher efficacy as anti-inflammatory agents and COX-2 inhibitors. These research findings not only introduce promising ibuprofen derivatives for therapeutic applications but also set the stage for future validation and exploration of this new generation of ibuprofen compounds.